These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 17036509)

  • 1. [The role of transforming growth factor-beta in the pathogenesis of diabetic retinopathy].
    Gacka M; Adamiec J
    Przegl Lek; 2006; 63(5):296-8. PubMed ID: 17036509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deficient activation and different expression of transforming growth factor-beta isoforms in active proliferative diabetic retinopathy and neovascular eye disease.
    Spranger J; Meyer-Schwickerath R; Klein M; Schatz H; Pfeiffer A
    Exp Clin Endocrinol Diabetes; 1999; 107(1):21-8. PubMed ID: 10077351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Role of insulin-like growth factor I in the development of diabetic retinopathy].
    Gacka M; Adamiec J
    Przegl Lek; 2003; 60(9):588-92. PubMed ID: 15065339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth factors and diabetic retinopathy.
    Paques M; Massin P; Gaudric A
    Diabetes Metab; 1997 Apr; 23(2):125-30. PubMed ID: 9137900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetic microvascular complications and growth factors.
    Pfeiffer A; Schatz H
    Exp Clin Endocrinol Diabetes; 1995; 103(1):7-14. PubMed ID: 7621107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-peptide and retinal microangiopathy in diabetes.
    Chakrabarti S; Khan ZA; Cukiernik M; Zhang W; Sima AA
    Exp Diabesity Res; 2004; 5(1):91-6. PubMed ID: 15198374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Transforming growth factor beta in the vitreous of patients with epiretinal proliferation].
    Gaudric A; Glacet-Bernard A; Clément G; Falquerho L; Barritault D; Coscas G
    Ophtalmologie; 1990; 4(1):51-2. PubMed ID: 2250941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of proliferative diabetic retinopathy.
    Gündüz K; Bakri SJ
    Compr Ophthalmol Update; 2007; 8(5):245-56. PubMed ID: 18201511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different expression of vascular endothelial growth factor and pigment epithelium-derived factor between diabetic and non-diabetic epiretinal membranes.
    Nam DH; Oh J; Roh JH; Huh K
    Ophthalmologica; 2009; 223(3):188-91. PubMed ID: 19182495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth factor alterations in advanced diabetic retinopathy: a possible role of blood retina barrier breakdown.
    Pfeiffer A; Spranger J; Meyer-Schwickerath R; Schatz H
    Diabetes; 1997 Sep; 46 Suppl 2():S26-30. PubMed ID: 9285495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucose-mediated regulation of transforming growth factor-beta (TGF-beta) and TGF-beta receptors in human retinal endothelial cells.
    Pascal MM; Forrester JV; Knott RM
    Curr Eye Res; 1999 Aug; 19(2):162-70. PubMed ID: 10420186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of angiotensin-converting enzyme inhibitors and beta-adrenergic blockers on retinal vascular endothelial growth factor expression in rat diabetic retinopathy.
    Zheng Z; Chen H; Xu X; Li C; Gu Q
    Exp Eye Res; 2007 Apr; 84(4):745-52. PubMed ID: 17303121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistologic study of interleukin-1, transforming growth factor-beta, and alpha-smooth muscle actin in lens epithelial cells in diabetic eyes.
    Hayashi Y; Kato S; Maeda T; Kaiya T; Kitano S
    J Cataract Refract Surg; 2005 Nov; 31(11):2187-92. PubMed ID: 16412937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple transforming growth factor-beta isoforms and receptors function during epithelial-mesenchymal cell transformation in the embryonic heart.
    Mercado-Pimentel ME; Runyan RB
    Cells Tissues Organs; 2007; 185(1-3):146-56. PubMed ID: 17587820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinal and choroidal TGF-beta in the tree shrew model of myopia: isoform expression, activation and effects on function.
    Jobling AI; Wan R; Gentle A; Bui BV; McBrien NA
    Exp Eye Res; 2009 Mar; 88(3):458-66. PubMed ID: 19046968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular matrix proteins in epiretinal membranes and in diabetic retinopathy.
    George B; Chen S; Chaudhary V; Gonder J; Chakrabarti S
    Curr Eye Res; 2009 Feb; 34(2):134-44. PubMed ID: 19219685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of alpha 4 integrin (CD49d) in the pathogenesis of diabetic retinopathy.
    Iliaki E; Poulaki V; Mitsiades N; Mitsiades CS; Miller JW; Gragoudas ES
    Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4898-904. PubMed ID: 19553613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New concepts in pathogenesis and treatment of diabetic retinopathy.
    Spranger J; Pfeiffer AF
    Exp Clin Endocrinol Diabetes; 2001; 109 Suppl 2():S438-50. PubMed ID: 11460590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does hypertension play a role in diabetic retinopathy?
    Srivastava BK; Rema M
    J Assoc Physicians India; 2005 Sep; 53():803-8. PubMed ID: 16334627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treating diabetic retinopathy by tackling growth factor pathways.
    Chiarelli F; Giannini C; Di Marzio D; Mohn A
    Curr Opin Investig Drugs; 2005 Apr; 6(4):395-409. PubMed ID: 15898347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.